Delivra Health Brands to Hold Conference Call to Discuss Results for the Year Ending June 30, 2024
Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF), a leader in consumer packaged goods in the health and wellness sector, has announced its upcoming annual financial results report for the year ending June 30, 2024. The company will host a conference call on Tuesday, October 8, 2024, at 11:00 a.m. (EST) / 8:00 a.m. (PST) to discuss these results.
The conference call will feature Gord Davey, President and CEO, and Jack Tasse, CFO, who will conduct a Q&A session following management's prepared remarks. Interested parties can join the call by dialing 1-844-763-8274 (Canada/USA Toll Free) or +1-647-484-8814 (International Toll). Participants are advised to dial in 10 minutes before the scheduled start time.
A replay of the call will be available on the company's investor page by the end of the business day on October 8, 2024.
Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF), un leader nel settore dei beni di consumo confezionati nel campo della salute e del benessere, ha annunciato il prossimo rapporto annuale sui risultati finanziari per l'anno conclusosi il 30 giugno 2024. L'azienda ospiterà una conferenza telefonica il martedì 8 ottobre 2024, alle 11:00 (EST) / 8:00 (PST) per discutere di questi risultati.
La conferenza telefonica vedrà la partecipazione di Gord Davey, Presidente e CEO, e di Jack Tasse, CFO, i quali condurranno una sessione di domande e risposte dopo le osservazioni preparate dalla direzione. Le parti interessate possono partecipare alla chiamata componendo il numero 1-844-763-8274 (Canada/USA Numero Verde) o +1-647-484-8814 (Numero Internazionale). Si consiglia ai partecipanti di chiamare 10 minuti prima dell'orario previsto.
Una registrazione della chiamata sarà disponibile sulla pagina investitori dell'azienda entro la fine della giornata lavorativa dell'8 ottobre 2024.
Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF), un líder en bienes de consumo empaquetados en el sector de la salud y el bienestar, ha anunciado su próximo informe anual de resultados financieros para el año que terminó el 30 de junio de 2024. La compañía llevará a cabo una conferencia telefónica el martes 8 de octubre de 2024, a las 11:00 a.m. (EST) / 8:00 a.m. (PST) para discutir estos resultados.
La conferencia contará con la participación de Gord Davey, Presidente y CEO, y Jack Tasse, CFO, quienes realizarán una sesión de preguntas y respuestas después de los comentarios preparados por la dirección. Las partes interesadas pueden unirse a la llamada marcando 1-844-763-8274 (Número Gratuito Canadá/EE.UU.) o +1-647-484-8814 (Número Internacional). Se aconseja a los participantes que llamen 10 minutos antes de la hora programada.
Una grabación de la llamada estará disponible en la página de inversores de la compañía al final del día hábil del 8 de octubre de 2024.
Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF), 건강 및 웰빙 분야의 소비재 선두주자로서, 2024년 6월 30일 종료 연도의 연간 재무 결과 보고서를 발표할 예정이라고 발표했습니다. 2024년 10월 8일 화요일 오전 11:00 (EST) / 오전 8:00 (PST)에 이러한 결과를 논의하기 위해 전화 회의를 개최할 것입니다.
이번 회의에는 Gord Davey, 사장 및 CEO와 Jack Tasse, CFO가 참석하여 경영진의 준비된 발언 뒤에 Q&A 세션을 진행할 예정입니다. 관심 있는 분들은 1-844-763-8274 (캐나다/미국 무료전화) 또는 +1-647-484-8814 (국제전화)로 전화 회의에 참여할 수 있습니다. 참가자들은 예정된 시작 시간보다 10분 전에 전화 연결할 것을 권장합니다.
전화 회의의 녹음은 2024년 10월 8일 영업일이 끝날 때까지 회사의 투자자 페이지에서 확인할 수 있습니다.
Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF), un leader dans le secteur des biens de consommation emballés dans le domaine de la santé et du bien-être, a annoncé son prochain rapport annuel sur les résultats financiers pour l'année se terminant le 30 juin 2024. L'entreprise tiendra une conférence téléphonique le mardi 8 octobre 2024, à 11h00 (EST) / 8h00 (PST) pour discuter de ces résultats.
La conférence téléphonique sera animée par Gord Davey, Président et CEO, et Jack Tasse, CFO, qui organiseront une séance de questions-réponses après les remarques préparées par la direction. Les parties intéressées peuvent rejoindre l'appel en composant le numéro 1-844-763-8274 (Canada/USA Numéro vert) ou +1-647-484-8814 (International). Il est conseillé aux participants de composer le numéro 10 minutes avant l'heure prévue.
Un replay de l'appel sera disponible sur la page investisseurs de l'entreprise d'ici la fin de la journée de travail le 8 octobre 2024.
Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF), ein führendes Unternehmen im Bereich der Verbraucherprodukte im Gesundheits- und Wellness-Sektor, hat seinen bevorstehenden Jahresbericht zu den finanziellen Ergebnissen für das am 30. Juni 2024 endende Jahr angekündigt. Das Unternehmen wird am Dienstag, dem 8. Oktober 2024, um 11:00 Uhr (EST) / 8:00 Uhr (PST) eine Telefonkonferenz abhalten, um diese Ergebnisse zu besprechen.
Die Telefonkonferenz wird Gord Davey, Präsident und CEO, und Jack Tasse, CFO umfassen, die nach den vorbereiteten Bemerkungen des Managements eine Q&A-Sitzung durchführen werden. Interessierte können der Konferenz beiwohnen, indem sie 1-844-763-8274 (Kanada/USA kostenlos) oder +1-647-484-8814 (International) anrufen. Es wird empfohlen, 10 Minuten vor dem geplanten Beginn einzuwählen.
Eine Aufzeichnung der Konferenz wird bis zum Ende des Geschäftstags am 8. Oktober 2024 auf der Investoren-Seite des Unternehmens verfügbar sein.
- None.
- None.
Vancouver, British Columbia--(Newsfile Corp. - October 2, 2024) - Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF) ("Delivra Health" or the "Company"), a consumer packaged goods leader uniquely positioned in the health and wellness sector, is pleased to announce it will report its annual financial results for the year ending June 30, 2024, on Tuesday, October 8, 2024.
Conference Call Details
The Company will host a conference call on Tuesday, October 8, 2024, at 11:00 a.m. (EST) / 8:00 a.m. (PST) to discuss the financial results for the year ending June 30, 2024. Gord Davey, President and Chief Executive Officer, and Jack Tasse, Chief Financial Officer of the Company will be conducting a question-and-answer session following management's prepared remarks.
Participant Dial-In Numbers:
All interested parties can join the conference call by dialing: 1-844-763-8274 (Canada/USA Toll Free) or +1-647-484-8814 (International Toll). Please dial in 10 minutes prior to the scheduled start time and ask to join the Delivra Health Brands call. A replay of the call will be available on the Company's investor page by the end of the business day on Tuesday, October 8, 2024.
About Delivra Health Brands Inc.
Helping people take control of their health with alternative wellness solutions is what energizes the Delivra Health team! The Delivra Health portfolio features innovative brands like Dream Water® and LivRelief™, which deliver relief from common everyday issues like chronic pain, anxiety, and sleeplessness. Delivra Health products have allowed millions of customers to reclaim their mobility, energy, and in turn, quality of life. The websites of the Company's two subsidiaries are Dream Water® and LivReliefTM. For more information, please visit www.delivrahealthbrands.com.
Cautionary Note Regarding Forward-Looking Statements
This news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates, and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as "expects", or "does not expect", "is expected", "anticipates" or "does not anticipate", "plans", "budget", "scheduled", "forecasts", "estimates", "believes" or "intends" or variations of such words and phrases or stating that certain actions, events or results "may" or "could", "would", "might" or "will" be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. In this news release, forward-looking statements include, among other things, statements with respect to the timing of reporting the Company's annual financial results for the year ending June 30, 2024, and the timing of the conference call.
These forward-looking statements are based on reasonable assumptions and estimates of management of the Company at the time such statements were made. Actual future results may differ materially as forward-looking statements involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance, or achievements of the Company to materially differ from any future results, performance, or achievements expressed or implied by such forward-looking statements. Such factors, among other things, include: fluctuations in general macroeconomic conditions; fluctuations in securities markets; expectations regarding the size of the cannabis markets where the Company operates; changing consumer habits; the ability of the Company to successfully achieve its business objectives; plans for expansion; political and social uncertainties; inability to obtain adequate insurance to cover risks and hazards; employee relations and the presence of laws and regulations that may impose restrictions on cultivation, production, distribution, and sale of cannabis and cannabis-related products in the markets where the Company operates. Although the forward-looking statements contained in this news release are based upon what management of the Company believes, or believed at the time, to be reasonable assumptions, the Company cannot assure shareholders that actual results will be consistent with such forward-looking statements, as there may be other factors that cause results not to be as anticipated, estimated or intended. Readers should not place undue reliance on the forward-looking statements and information contained in this news release. The Company assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law.
Additional information regarding this and other risks and uncertainties relating to the Company's business are contained under the heading "Risk Factors" in the Company's annual information form dated March 2, 2021, and under the heading "Risks and Uncertainties" in the Company's management's discussion and analysis dated May 15, 2024, for the three and nine months ended March 31, 2024, filed under the Company's profile on SEDAR+ at www.sedarplus.ca.
Neither TSX Venture Exchange or its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this release.
Investor Relations:
Jack Tasse
Chief Financial Officer
IR@delivrahealth.com
1-877-915-7934
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/225399
FAQ
When will Delivra Health Brands (DHBUF) report its annual financial results for 2024?
What time is the Delivra Health Brands (DHBUF) conference call scheduled for October 8, 2024?
Who will be conducting the Q&A session during Delivra Health Brands' (DHBUF) conference call?
What are the dial-in numbers for Delivra Health Brands' (DHBUF) October 8, 2024 conference call?